← Back to Search

Behavioural Intervention

TEST Lens for Ocular Physiology

N/A
Waitlist Available
Research Sponsored by Johnson & Johnson Vision Care, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 2-week follow-up
Awards & highlights

Study Summary

This trial will compare the severity of itchy eyes between two groups of people wearing different contact lenses, over the course of two weeks.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 2-week follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 2-week follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Subjective rating of itchiness
Secondary outcome measures
CLDEQ-8 Questionnaire
Comfortable and total CL wear time
MiniRQLQ Questionnaire
+5 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: TEST/CONTROLExperimental Treatment2 Interventions
Eligible subjects who suffer from ocular allergies and who wear contact lenses will be randomized into the wear sequence (TEST/CONTROL) to wear the study lenses during each dispensing period (12-16 days).
Group II: CONTROL/TESTExperimental Treatment2 Interventions
Eligible subjects who suffer from ocular allergies and who wear contact lenses will be randomized into the wear sequence (CONTROL/TEST) to wear the study lenses during each dispensing period (12-16 days).
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
TEST Lens
2018
N/A
~130
CONTROL Lens
2018
N/A
~130

Find a Location

Who is running the clinical trial?

Johnson & Johnson Vision Care, Inc.Lead Sponsor
216 Previous Clinical Trials
25,561 Total Patients Enrolled
Johnson & Johnson Vision Care, Inc. Clinical TrialStudy DirectorJohnson & Johnson Vision Care, Inc.
44 Previous Clinical Trials
4,435 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities still available to join this research endeavor?

"Online data from clinicaltrials.gov suggests that this trial, which was first published on December 30th 2022 and last edited on November 28th 2022, has closed its recruitment process; however, there are still 1 other trials actively seeking participants."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Evaluating Quality of Life Benefits of ACUVUE® Theravision® With Ketotifen in Subjects With Ocular Allergies
2024. "Evaluating Quality of Life Benefits of ACUVUE® Theravision® With Ketotifen in Subjects With Ocular Allergies". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05530889.
~0 spots leftby May 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top